Skip to main content
. Author manuscript; available in PMC: 2011 May 26.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Feb 16;19(3):799–810. doi: 10.1158/1055-9965.EPI-09-1138

Table 1.

Adjusted weighted percentages of cancer reports with varying levels of consistency and site-specificity in relatives with a positive cancer history*

Type of report** Reports About All Relatives (N=2,657 reports) Reports About First-degree Relatives (N=918 reports) Reports About Second-degree Relatives (N=1,739 reports)
% (95% C.I.) % (95% C.I.) % (95% C.I.)
Consistent with malignancy 97.7 (96.9–98.3) 95.3 (93.3–96.7) 98.9 (98.2–99.3)
 well-defined site 79.0 (77.0–80.8) 86.6 (83.6–89.2) 75.0 (72.3–77.6)
 unspecified site 10.1 (8.5–11.9) 2.1 (1.2–3.8) 14.2 (11.8–16.9)
 ill-defined site 8.6 (7.5–9.9) 6.5 (4.8–8.7) 9.7 (8.2–11.4)
Not consistent with malignancy 1.3 (0.9–1.9) 2.9 (1.9–4.3) 0.4 (0.2–1.0)
Indeterminate 1.1 (0.7–1.7) 1.8 (0.9–3.8) 0.7 (0.4–1.2)
*

After identifying 2,408 relatives (781 first-degree and 1,627 second-degree) with a cancer history, the 1,019 respondents were asked to report the cancer type or where in the body the cancer started. All percentages of cancer reports are weighted to the Connecticut population and adjusted for differential selection probabilities, rates of non-response, and post-stratification.

**

See Figure 1 for examples of reports in the different categories.